{"listableLinks":null,"documentId":38461,"title":"2019 IQVIA Report - The Impact of Biosimilar Competition in Europe","language":"en","attachments":[{"listableLinks":null,"title":"2019 IQVIA Report - The Impact of Biosimilar Competition in Europe","language":"EN","nativeRenditionSize":2210879,"pdfRenditionSize":2236103,"renditionAvailable":true,"version":"1.0","translations":[{"listableLinks":null,"title":"2019 IQVIA Report - The Impact of Biosimilar Competition in Europe","language":"EN","nativeRenditionSize":2210879,"pdfRenditionSize":2236103,"renditionAvailable":true,"version":null,"translations":null,"fileName":"IQVIA Biosimilars EC Whitepaper ORB2731F.pdf","sortOrder":null,"links":[{"rel":"native","href":"https://ec.europa.eu/docsroom/documents/38461/attachments/1/translations/en/renditions/native"},{"rel":"pdf","href":"https://ec.europa.eu/docsroom/documents/38461/attachments/1/translations/en/renditions/pdf"}]}],"fileName":"IQVIA Biosimilars EC Whitepaper ORB2731F.pdf","sortOrder":1,"links":[{"rel":"native","href":"https://ec.europa.eu/docsroom/documents/38461/attachments/1/translations/en/renditions/native"},{"rel":"pdf","href":"https://ec.europa.eu/docsroom/documents/38461/attachments/1/translations/en/renditions/pdf"}]}],"urlRedirect":null,"externalizationDate":1575272826000,"firstExternalizationDate":null,"lastUpdateDate":1575276389000,"registererService":"grow.ddg1.d.dir","tags":[],"keywords":["pharmaceutical industry","medicine","public health"],"links":[{"rel":"self","href":"https://ec.europa.eu/docsroom/documents/38461"}]}